# COVID-19 and Venous Thromboembolism Risk

> **NCT04569344** · — · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 398530 (actual)

## Conditions studied

- Venous Thromboembolism
- Covid19

## Interventions

- **OTHER:** Laboratory test positive for SARS-CoV-2 virus

## Key facts

- **NCT ID:** NCT04569344
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2021-02-28
- **Final completion:** 2022-06-21
- **Target enrollment:** 398530 (ACTUAL)
- **Last updated:** 2022-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04569344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04569344, "COVID-19 and Venous Thromboembolism Risk". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04569344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*